By Therapeutic Area

Pharmacogenomics Market Analysis

Cross-industry research covering Pharmacogenomics across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports
1 Industries

Reports Covering Pharmacogenomics

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

Pharmacogenomic panels — covering CYP2C19, CYP2D6, SLCO1B1, and related drug-metabolism loci — represent the segment with the clearest clinical utility argument and the shortest path to payer reimbursement. Health system integration, particularly through EMR-linked result delivery, is the key differentiator separating clinical-grade operators from pure DTC players.

14%

Market Share

10.4%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments